ARMP
HealthcareArmata Pharmaceuticals, Inc.
$6.35
$-0.21 (-3.20%)
Jan 5, 2026
Price History (1Y)
Analysis
Armata Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector with approximately 60 employees. It has a market capitalization of $231.18M and annual revenues of $5.05M. The company's financial health is concerning, with operating margins reaching -670.9% and a profit margin of 0.0%. Additionally, it reported net income losses of -$46,901,000 in the last four quarters. The balance sheet indicates cash reserves of $14.76M but significant debt totaling $177.68M. Returns on equity (ROE) and assets (ROA) are not available for review. Armata Pharmaceuticals' valuation metrics are also noteworthy. With a price-to-sales ratio of 45.74, it is significantly valued compared to its peers. Furthermore, the company's forward P/E ratio stands at -4.04, indicating potential investors should carefully consider this metric in their analysis. The revenue growth rate has been negative at -61.0% year-over-year, and dividend yield is not applicable due to the absence of dividends.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Visit website →Key Statistics
- Market Cap
- $231.18M
- P/E Ratio
- N/A
- 52-Week High
- $16.34
- 52-Week Low
- $0.90
- Avg Volume
- 293.62K
- Beta
- 1.31
Company Info
- Industry
- Biotechnology
- Exchange
- ASE
- Country
- United States
- Employees
- 60